PTIXW - Protagenic Therapeutics Inc - Warrants (13/04/2025)
Previous close
0.0106
0 0%
Share volume: 101
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.01
0.00
0.00%
Fundamental analysis
4%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
10%
Performance
5 Days
12.77%
1 Month
-26.39%
3 Months
-59.23%
6 Months
6.00%
1 Year
-53.91%
2 Year
-75.23%
Key data
Stock price
$0.01
DAY RANGE
N/A - N/A
52 WEEK RANGE
$0.00 - $0.04
52 WEEK CHANGE
-$0.70
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO:
Region: US
Website: protagenic.com
Employees: 1
IPO year: -
Issue type:
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: protagenic.com
Employees: 1
IPO year: -
Issue type:
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
protagenic therapeutics is a biotechnology company located in 1625th ave, new york, new york, united states.
Recent news